SULIMAN SHEHNAAZ 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
SULIMAN SHEHNAAZ
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+7,110→ 7,110 totalExercise: $51.82Exp: 2033-06-07→ Common Stock (7,110 underlying) - Award
Common Stock
2023-06-07+3,860→ 14,855 total
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.